US Broker Ratings

Genmab A/S (GMAB) Stock Analysis: Evaluating a 46% Potential Upside in Biotechnology

Genmab A/S (GMAB), a prominent player in the biotechnology sector, presents an intriguing investment opportunity, particularly for those focused on the healthcare industry. With a market..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 9.48% Potential Upside in Medical Devices

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a significant player in the healthcare sector, specifically within the medical devices industry. With a robust market..

United Therapeutics Corporation (UTHR) Stock Analysis: A 29% Potential Upside in the Healthcare Sector

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the healthcare sector, is attracting investor attention with a promising potential upside of 29.09%. Specializing in the..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating the Upside in RNAi Therapeutics

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) has been a prominent player in the biotechnology sector, focusing on the innovative field of ribonucleic acid interference (RNAi) therapeutics. With..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating a 23% Upside Potential in the Healthcare Sector

Universal Health Services, Inc. (NYSE: UHS) presents a compelling opportunity for investors with its robust position in the healthcare sector, particularly in the medical care facilities..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Strong Revenue Growth in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL), a leading player in the biotechnology sector, is a company that has caught the attention of investors with its focus on discovering..

Stevanato Group S.p.A. (STVN)

⚠️ No article content returned.

..

Regeneron Pharmaceuticals, Inc. (REGN): Investor Outlook Reveals 32.86% Upside Potential

Regeneron Pharmaceuticals, Inc. (NYSE: REGN), a leading biotechnology company in the United States, is capturing investor interest with a significant potential upside of 32.86%, according to..

Chemed Corp (CHE) Stock Analysis: Strong Buy Ratings and a 36% Potential Upside

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, is capturing investor attention with its robust performance metrics and promising growth potential. As a..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: High Dividend Yield and Potential Upside Amid Challenging Metrics

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a prominent player in the healthcare sector, firmly rooted in the pharmaceutical retail industry. As a company with..

DaVita Inc. (DVA) Stock Analysis: Evaluating the 11.63% Potential Upside in the Healthcare Sector

DaVita Inc. (DVA), a prominent player in the healthcare sector specializing in kidney dialysis services, is capturing investor attention with a market cap of $10.77 billion...

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Navigating Growth with a 59.33% Return on Equity

In the dynamic landscape of healthcare diagnostics, IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands out as a formidable player. With a market capitalization of $43.99 billion, IDEXX..

Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Leader with a Strong Growth Trajectory

Doximity, Inc. (NYSE: DOCS) continues to carve out a significant niche in the healthcare sector, positioning itself as a key player in health information services. With..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Analyst Ratings and 19% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the healthcare sector, stands out in the health information services industry with its robust offering of technology-enabled services..

Revvity, Inc. (RVTY) Stock Analysis: Unpacking a 22.58% Upside Potential

Revvity, Inc. (NYSE: RVTY) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a robust market capitalization of $11.94 billion,..

Repligen Corporation (RGEN) Stock Analysis: Exploring a 42% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN) has caught the attention of investors, particularly those interested in the healthcare sector. As a key player in the medical instruments and..

McKesson Corporation (MCK) Stock Analysis: Navigating Healthcare with a $89.84 Billion Market Cap

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, continues to command investor attention with its robust market positioning and expansive operational footprint. As a..

DexCom, Inc. (DXCM) Stock Analysis: A Promising 18.88% Potential Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector, particularly in medical devices, continues to stand out with its innovative continuous glucose monitoring (CGM) systems...

Moderna, Inc. (MRNA): Investor Outlook Reveals 56% Potential Upside Amidst Volatile Market Conditions

As a key player in the biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) has garnered significant attention from investors, particularly with its innovative messenger RNA (mRNA) technology...

The Cooper Companies, Inc. (COO) Investor Outlook: Assessing a 26.91% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, offers considerable potential for investors seeking exposure to the medical instruments and supplies..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds